House greenlights psychedelic research in NDAA, drug shortage and PBM reforms to come

The House of Rep­re­sen­ta­tives passed its wide-reach­ing de­fense spend­ing bill Fri­day on a large­ly par­ty-line vote, green­light­ing a bi­par­ti­san pro­vi­sion that would di­rect the De­part­ment of De­fense to car­ry out stud­ies on the use of psy­che­delics to treat ser­vice mem­bers with con­di­tions like post-trau­mat­ic stress dis­or­der.

With about two weeks un­til Au­gust re­cess, Con­gress’ phar­ma-re­lat­ed to-do list of PBM and drug short­age re­forms, as well as pan­dem­ic pre­pared­ness, will like­ly wait for the fall.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN